Alfacalcidol-Stimulated Focal Bone Formation on the Cancellous Surface and Increased Bone Formation on the Periosteal Surface of the Lumbar Vertebrae of Adult Female Rats
- 108 Downloads
To investigate the skeletal effects of alfacalcidol alone or in combination with exercise in intact adult female rats.
Seventy-four 8.5-month-old rats were orally administered 0, 0.005, 0.025, 0.05 or 0.1 μg/kg of alfacalcidol for 12 weeks, alone or in combination with exercise. Cancellous bone histomorphometric measurements were performed on the second lumbar vertebra.
At 0.05 and 0.1 μg/kg, alfacalcidol caused a significant increase in cancellous bone volume, accompanied by an increase in trabecular architecture. Percent eroded surface, bone resorption and formation were suppressed by alfacalcidol treatment. However, mineral apposition rate was significantly increased, indicating osteoblast activity was increased. A positive balance between bone formation and resorption was observed in the rats treated with the highest dose of alfacalcidol. Alfacalcidol induced a unique bone formation site (“bouton”) on the cancellous surface. These boutons connected adjacent trabeculae and increased trabecular thickness. They exhibited both smooth and scalloped cement lines, suggesting that they were formed by minimodeling- and remodeling-based bone formation. Furthermore, alfacalcidol at 0.1 μg/kg increased periosteal bone formation of the lumbar transverse processes. Bipedal stance exercise alone did not have an effect on bone balance and bone turnover. There were no interactions between alfacalcidol and bipedal stance exercise except for a decrease in bone resorption.
Alfacalcidol exhibited both anti-catabolic and anabolic effects on bone in intact female rats. The effect of combined treatment with alfacalcidol and bipedal stance exercise was no better than that of alfacalcidol alone.
KeywordsAlfacalcidol Anabolic Anti-catabolic Exercise Histomorphometry
- 3.Reid IR (1996) Vitamin D and its metabolites in the management of osteoporosis. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis. Academic Press, New York, pp 1169–1190Google Scholar
- 8.Shiraki M, Ito H, Orimo H (1992) The ultra long-term treatment of senile osteoporosis with 1α-hydroxyvitamin D3. Bone Miner 20:223–234Google Scholar
- 14.Shiraishi A, Takeda S, Masaki T, Higuchi Y, Uchiyama Y, Kubodera N, Sato K, Ikeda K, Nakamuta T, Matsumoto T, Ogata E (2000) Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: Distinct actions from estrogen. J Bone Miner Res 15:770–779PubMedCrossRefGoogle Scholar
- 21.Li M, Li Y, Healy DR, Simmons HA, Ke HZ, Thompson DD (2003) Alfacalcidol restores cancellous bone in ovariectomized rats. J Musculoskelet Neuronal Interact 3:29–46Google Scholar
- 25.Aloia JF, Cohn SH, Ostuni JA, Cane R, Ellis K (1978) Prevention of involuntary bone loss by exercise. Ann Intern Med 89:365–358Google Scholar
- 28.Kirk S, Rude RK (1989) Effects of long-distance running on bone mass in women. J Bone Miner Res 4:59–63Google Scholar
- 29.Peacock NA, Eisman JA, Yeatesm MG, Sambrook PN, Eberi S (1986) Physical fitness is a major determinant of femoral neck and lumbar spine bone mineral density. J Clin Invest 78:618–621Google Scholar
- 33.Yao W, Jee WSS, Frost HM (2001) A novel model to exercise rats: Making rats assume bipedal stance for feeding—raised cage model. J Musculoskelet Neuronal Interact 3:241–247Google Scholar
- 39.Pataki A, Muller K, Green JR, Ma YF, Li QN, Jee WS (1997) Effects of short-term treatment with the bisphosphonates zoledronate and pamidronate on rat bone: A comparative histomorphometric study on the cancellous bone formed before, during, and after treatment. Anat Rec 249:458–468PubMedCrossRefGoogle Scholar
- 45.Takahashi HE, Hattner R, Epker B, Frost HM (1964) Evidence that bone resorption precedes formation at the cellular level. Henry Ford Hosp Med Bull 12:359–364Google Scholar
- 48.Parfitt AM (2002) Recent contributions of iliac bone histomorphometry to understanding the anabolic effect of parathyroid hormone. IBMS BoneKEy, Jan 29. doi: 10.1138/2002017
- 49.Ma YL, Donley W, Eriksen EF (2003) Characteristics of modeling and remodeling osteons after teriparatide treatment. Bone 32:S225Google Scholar
- 51.Lindsay R, Cosman F, Zhou H, Bostrom MP, Shen VW, Cruz JD, Nieves JW, Dempster DW (2006) A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: Early actions of Teriparatide. J Bone Miner Res 21:366–373PubMedCrossRefGoogle Scholar
- 52.Frost HM (2004) The Utah paradigm of skeletal physiology, chapters 3 and 4. International Society of Musculoskeletal and Neuronal Interactions, Athens, Greece, 2004Google Scholar
- 53.Erben EG (1996) Trabecular and endocortical bone surfaces in the rat: modeling and remodeling? Anat Rec 246:39–46Google Scholar
- 58.Garn SM (1970) The earlier gain and later loss of cortical bone. Charles C Thomas, Springfield, ILGoogle Scholar
- 59.Jee WSS (2000) Anabolic agents and osteoporosis: Quo vadis? J Musculoskelet Neuronal Interact 1:207–211Google Scholar